Gemseki

Gemseki operates a digital marketplace connecting originators of high-potential drug candidates and platform technologies with prospective licensees. This platform enables academic institutions and biotechs to present discoveries to global pharmaceutical and biotechnology firms, efficiently accelerating early-stage biomedical research into commercial development.

The company emerged as a business division of Shin Nippon Biomedical Laboratories (SNBL), a leading Japanese nonclinical contract research organization. Gemseki leverages SNBL’s resources, founded on the insight that a dedicated platform could more effectively identify and commercialize promising drug discoveries, bridging innovation and development.

Gemseki’s platform serves academic researchers seeking to out-license intellectual property and pharmaceutical companies pursuing new pipeline assets. Its vision is to act as a crucial intermediary, unlocking novel therapeutics' potential by fostering strategic partnerships across the global biomedical ecosystem, advancing new medical treatments.